Evidence supporting the use of: Norepinephrine
For the health condition: Congestive Heart Failure

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Norepinephrine is a potent vasoconstrictor and inotropic agent that is sometimes used in the management of acute decompensated heart failure, particularly when accompanied by cardiogenic shock or severe hypotension. Its primary mechanism of action is stimulation of alpha-adrenergic receptors, resulting in vasoconstriction and increased systemic vascular resistance, as well as some beta-1 adrenergic stimulation, which can increase cardiac contractility and heart rate. These effects can help maintain adequate perfusion pressure in critically ill patients with heart failure and hypotension.

The use of norepinephrine in congestive heart failure (CHF) is not routine and is generally reserved for cases of acute decompensation with low blood pressure, where other inotropes and vasopressors may also be considered. Scientific evidence for its use is largely based on clinical experience and observational studies, along with data from randomized trials of vasopressor use in cardiogenic shock (such as the SOAP II trial), which suggest that norepinephrine may be safer and more effective than dopamine for treating hypotension in the setting of cardiac dysfunction. However, norepinephrine is not considered a first-line therapy for chronic management of CHF, as long-term use can increase cardiac workload and potentially worsen outcomes. Guidelines recommend its use only for life-threatening hypotension in acute settings.

Overall, norepinephrine is supported by scientific evidence for short-term hemodynamic support in acute heart failure with shock, but not for chronic CHF management.

More about Norepinephrine
More about Congestive Heart Failure

Products containing Norepinephrine

We currently have no products on Vitabase that contain this ingredient.